Phase IIa randomized placebocontrolled clinical trial to evaluate the efficacy of bromhexine in combination with standard therapy in the early treatment of COVID-19 in primary care patients
Since coughing is one of the primary forms of transmission for SARS-CoV-2, the observed reduction of coughing might be highly beneficial, particularly for patients living in crowded, poorly ventilated, or confined environments.
Authors
- Miguel Iván Reyes-Parada (ORCID: https://orcid.org/0000-0002-2376-990X)
- Romina Rojas (ORCID: https://orcid.org/0000-0001-8209-6453)
- Daniela Nova
- David Ramírez
- Estíbaliz Ampuero (ORCID: https://orcid.org/0000-0001-5543-1594)
- Carmen Gil (ORCID: https://orcid.org/0000-0002-3882-6081)
- Georgina M. Renard (ORCID: https://orcid.org/0000-0002-5439-7547)
- Humberto Fierro
- Jorge Fuentealba
- Ana Martínez
Institutions
- Universidad de Santiago de Chile (CL)
- University of Concepción (CL)
- Universidad Autónoma de Chile (CL)
- Centro de Investigaciones Biológicas Margarita Salas (ES)
Publication Details
- Journal
- Revista médica de Chile
- Published
- 2024-12-01
- DOI
- https://doi.org/10.4067/s0034-98872024001201198
- Primary Topic
- Pharmacological Receptor Mechanisms and Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agencia Nacional de Investigación y Desarrollo
- Departamento de Investigaciones Científicas y Tecnológicas, Universidad de Santiago de Chile